
|Articles|August 1, 2006
- Volume 0 0
Generic Drug Sales Raise Walgreene' Bottom Line
Advertisement
Walgreen Co, the nation's largest drugstore chain, attributed much of its strong 14% increase in quarter profits to climbing sales of generic drugs during the first few months of 2006. In part, the double-digit rise in Walgreen profits came as a result of the Medicare Part D prescription drug benefit, which brought a flood of additional senior citizens into its drugstores. Officials at the chain, however, said increased sales of generics also played a key role.
Articles in this issue
almost 20 years ago
Questions and Answers About Dry Mouthalmost 20 years ago
Kidney Stonealmost 20 years ago
Rx Productsalmost 20 years ago
can you READ these Rxs?almost 20 years ago
OTC Productsalmost 20 years ago
Discrimination in Design of an Rx Drug Insurance Program?almost 20 years ago
compounding HOTLINEalmost 20 years ago
A Calming Influence: An Analysis of ADHD Treatmentsalmost 20 years ago
Carbinoxamine Products Still Within Reachalmost 20 years ago
Wal-Mart Pharmacist of the Year: Indispensable to Her CommunityAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































